16 results · 27ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

ANTI-EMBOLISM STOCKINGS, MODELS 71055-00000-02, 71057-00000-02, 71059-00000-02, 71064-00000-02 & 71065-00000-02

FDA 510(k)
FDA Class 2 ·General Hospital

ADULT DUAL HEATED BREATHING CIRCUIT

FDA Adverse Event
Malfunction ·FISHER & PAYKEL HEALTHCARE LTD·Product code BTT·June 23, 2010

TraXis®

FDA UDI
ZIMMER SPINE, INC.·00889024332836·

TraXis®

FDA UDI
ZIMMER SPINE, INC.·00889024332959·

ADVANTAGE MARIJUANA (THC) HOME DRUG TEST

FDA 510(k)
FDA Class 2 ·Clinical Toxicology

BAYER ADVIA IMS SYSTEM; 200 + 3

FDA 510(k)
FDA Class 2 ·Immunology

AUTOFEED HUMIDIFICATION CHAMBER

FDA Adverse Event
Malfunction ·FISHER & PAYKEL HEALTHCARE LTD·Product code BTT·April 21, 2010

ADULT DUAL HEATED BREATHING CIRCUIT

FDA Adverse Event
Malfunction ·FISHER & PAYKEL HEALTHCARE, LTD.·Product code BTT·June 25, 2010

OT VERIO IQ METER

FDA Adverse Event
Malfunction ·LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL·Product code NBW·May 2, 2013

OT VERIO PRO METER

FDA Adverse Event
Malfunction ·LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL·Product code NBW·September 16, 2014

PARADIGM REAL-TIME INSULIN INFUSION PUMP

FDA Adverse Event
Injury ·MEDTRONIC MINIMED·Product code MDS·May 2, 2011

TraXis Vue Spinal Implant System, Part #2601-090921

FDA Recall
Terminated ·Abbott Spine·Product code MQP·November 2, 2005

FLEXCERA BASE -a Dental resins for the fabrication of artificial teeth

FDA Enforcement
Class II ·Ongoing·Envisiontec US Llc·February 23, 2022

FLEXCERA SMILE -a Dental resins for the fabrication of artificial teeth

FDA Enforcement
Class II ·Ongoing·Envisiontec US Llc·February 23, 2022

Medshape Universal Joints, REF: DNE-9000-UJ

FDA Enforcement
Class II ·Ongoing·Medshape, INC.·September 10, 2025

OPAQUE Herrick Lacrimal Plugs, HP3, 0.3 mm, HP5, 0.5mm, HP7, 0.7.mm, STERILE, EO, Rx only, CE Dry eye treatment

FDA Enforcement
Class II ·Ongoing·Lacrimedics Inc·March 9, 2022